Premium
Intrahepatic distribution of transforming growth factor‐alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis
Author(s) -
Burr Andrew W.,
Carpenter Martyn R.,
Hines Julie E.,
Gullick William J.,
Burt Alastair D.
Publication year - 1993
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.1711700115
Subject(s) - liver regeneration , polyclonal antibodies , autocrine signalling , biology , transforming growth factor , growth factor , cell growth , immunohistochemistry , hepatocyte , microbiology and biotechnology , endocrinology , medicine , regeneration (biology) , antibody , immunology , cell culture , biochemistry , in vitro , receptor , genetics
The distribution of transforming growth factor‐alpha (TGFα) in rat liver during regeneration was studied immunohistochemically using two antibodies, one a polyclonal (26T) raised against a synthetic peptide corresponding to the 17 C‐terminal amino acids of the mature rat protein, and the other a monoclonal (Ab‐2) raised against recombinant human protein. In normal liver, immunoreactive TGFα was detected in perivenular hepatocytes using both antibodies. No sinusoidal cells were found to contain the peptide. In response to carbon tetrachloride (CCI 4 )‐induced necrosis, an initial increase in the intensity of immunoreactivity was noted at 24 h following exposure to the toxin. This coincided with the period immediately preceding the peak of hepatocyte proliferation; Ab‐2 immunoreactive cells outnumbered 26T‐positive cells. Thereafter there was a reduction in the number of TGFα‐positive cells, but by day 4 the level of immunoreactivity had returned to that of normal liver. Using bromodeoxyuridine labelling, spatial and temporal relationships between TGFα expression and cell proliferation were identified, supporting the concept that this peptide plays an important role in the in vivo regenerative response to hepatic injury via an autocrine mechanism.